Four Yale Researchers Honored at the 2022 Association for Clinical and Translational Science Awards
The collaboration that advanced the discovery of ketamine as a treatment for depression was among four Yale award winners at the Association for Clinical and Translational Science (ACTS) annual meeting held in Chicago from April 20 through 22.
YCCI’s Tesheia Johnson Appointed to CTSA Steering Committee
The National Center for Advancing Translational Sciences (NCATS) has announced the new members of its Clinical and Translational Science Awards (CTSA) Program steering committee, including Yale School of Medicine Director of Clinical Research and Yale Center for Clinical Investigation (YCCI) Chief Operating Officer Tesheia Johnson, MBA, MHS. The steering committee provides direction to NCATS and the more than 60 CTSA-funded institutions around the country, including Yale.
Yale Scientists Awarded $8.4M Grant to Develop Treatments for Women With Problem Drinking
Yale Department of Psychiatry scientists have been awarded a five-year, $8.4 million federal grant to establish a new research center at Yale that will develop treatments to help women with problem drinking.
Yale Genomics Study: Helping Researchers Better Understand the Opioid Epidemic
A human genomics study led by two Yale Department of Psychiatry researchers identified specific genetic regions that link opioid exposure and dependence to neuropsychiatric traits like risk-taking behaviors, alcohol abuse, and depression.
Grilo Guest Co-Editor on Special Issue of American Psychologist
Carlos Grilo, PhD, Professor of Psychiatry and of Psychology and Director of the Yale Program for Obesity Weight and Eating Research, served as guest co-editor on a special issue titled "Obesity: Psychosocial and Behavioral Aspects of a Modern Epidemic" in the February/March issue of the American Psychologist, the official peer-reviewed scholarly journal of the American Psychological Association.
Yale School of Medicine and FDA’s Office of Minority Health and Health Equity Diversity Day: "Patient Centered Approach to Care and Research" on Feb. 28
The Innovation and Diversity Summit will focus on raising awareness about the need for minorities and subpopulation participation in clinical trials; patient-centered approaches to care and research; and the role of technology in both areas.
How the Brain Helps Us Make Good Decisions — and Bad Ones
A prevailing theory in neuroscience holds that people make decisions based on integrated global calculations that occur within the frontal cortex of the brain. However, Yale researchers have found that three distinct circuits connecting to different brain regions are involved in making good decisions, bad ones, and determining which of those past choices to store in memory, they report June 25 in the journal Neuron.
Sestan Honored for Research in Developmental Neuroscience
Nenad Sestan, MD, PhD, Harvey and Kate Cushing Professor of Neuroscience, and Professor of Comparative Medicine, Genetics, and Psychiatry, received the Constance Lieber prize for innovation in developmental neuroscience on June 19 at a prize symposium at in Baltimore, MD.
Women’s Health Research at Yale funds studies on pain relief, cannabis, and genetic origins of sex differences in disease
Women’s Health Research at Yale (WHRY) today announced funding for first-of-their-kind studies on pain relief, cannabis, and the genetic basis of sex differences across a broad range of ailments, including Alzheimer’s disease and heart disease.
Biomarker Reveals PTSD Sufferers at Risk of Suicide
The risk of suicide among individuals with post-traumatic stress disorder (PTSD) is much higher than the general population, but identifying those individuals at greatest risk has been difficult. However, a team at Yale has discovered a biological marker linked to individuals with PTSD who are most likely to think about suicide, the researchers report May 13 in the journal Proceedings of the National Academy of Sciences.
Speeding Treatment Blunts the Worst of Schizophrenia
An interdisciplinary program called Specialized Treatment Early in Psychosis, founded by Vinod Srihari, MD, is helping speed treatment of schizophrenia. How quickly the condition is diagnosed and treated can determine a patient’s odds of living a relatively normal, albeit medicated, life.Source: Yale Medicine
Yonkers, Forray Co-PIs on New Grant to Study Medication Delivery for Pregnant Women with Opioid Use Disorders
Kimberly Yonkers, MD, Professor of Psychiatry, of Epidemiology (Chronic Diseases) and of Obstetrics, Gynecology, and Reproductive Services, and Ariadna Forray, MD, Associate Professor of Psychiatry, are co-principal investigators on a new $5.5 million grant to study models to improve delivery of office-based medication treatment for pregnant women with opioid use disorder in prenatal clinics.
Yale Researchers Study Association of Economic Status and Educational Attainment with PTSD
Renato Polimanti, PhD, MSc, Assistant Professor of Psychiatry, is the lead author of a genome-wide study that found economic status mediates negative associations of cognitive ability and educational attainment in people with posttraumatic stress disorder (PTSD).
Krystal Among New Leaders of YCCI
The Yale Center for Clinical Investigation (YCCI) has announced the appointment of Brian R. Smith, MD, and John H. Krystal, MD ’84, as co-directors of the center and co-principal investigators of Yale’s Clinical and Translational Science Award (CTSA). Eric Jose Velazquez, MD, becomes deputy director of clinical trials innovation for YCCI.